NASDAQ
Applied Therapeutics, Inc. (APLT) reported revenue of $455.00K and net income of $-105,624,000 for FY 2024, with a net profit margin of -23214.1%. Revenue represents total sales while net income is the profit remaining after all expenses. The relationship between them reflects overall profitability.
No price data available for this timeframe.